Wexford Capital’s Dentsply Sirona XRAY Stock Holding History

Wexford Capital’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,643	Closed	-$98.8K	–	396
2025 Q4	$98.8K	Buy	+8,643	New	+$101K	0.02%	260

Other funds holding XRAY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Wexford Capital's XRAY Position: Q1 2026 in Review

Wexford Capital sold out of Dentsply Sirona (XRAY) in Q1 2026, closing a stake of 8,643 shares — an estimated $98.8K sold.

Wexford Capital first reported a position in XRAY in Q4 2025 and held it in 1 quarter. The position peaked at $98.8K in Q4 2025. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

Wexford Capital reported no remaining Dentsply Sirona position as of Q1 2026 after selling out during the quarter.
Wexford Capital sold 8,643 Dentsply Sirona shares in Q1 2026, an estimated $98.8K.
Wexford Capital first reported a position in Dentsply Sirona in Q4 2025 and held it in 1 quarter.
Wexford Capital's Dentsply Sirona position peaked at $98.8K in Q4 2025.
382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Wexford Capital's 13F filing for Q1 2026, filed 15 May 2026.